Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Latvia Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20056
20063
20074
20082
20098
20105
20112
20126
20134
20141
20151
20163
20172
20183
20191
20202
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated10
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda8
AstraZeneca7
Novo Nordisk A/S7
GlaxoSmithKline6
Sanofi6
Boehringer Ingelheim5
Hoffmann-La Roche5
Lexicon Pharmaceuticals3
Novartis Pharmaceuticals3
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 259
Diabetes Mellitus13
Cardiovascular Diseases6
Glucose Metabolism Disorders5
Dyslipidemias3
Glucose Intolerance3
Heart Failure3
Hyperglycemia3
Metabolic Diseases3
Diabetes Mellitus, Lipoatrophic2

Trials

Showing 26 to 50 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.